Literature DB >> 2026121

On the paradox of insulin-induced hyperandrogenism in insulin-resistant states.

L Poretsky1.   

Abstract

I have reviewed recent studies that shed light on the paradox of insulin-induced ovarian hyperandrogenism in insulin-resistant states. Depending on the circumstances of the particular syndrome, insulin could act on the ovaries of insulin-resistant patients by activating IGF-I receptors, insulin receptors, hybrid insulin/IGF-I receptors, or any combination of these receptors. Further studies will uncover precise mechanisms of insulin-induced ovarian hyperstimulation in specific syndromes of insulin resistance.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2026121     DOI: 10.1210/edrv-12-1-3

Source DB:  PubMed          Journal:  Endocr Rev        ISSN: 0163-769X            Impact factor:   19.871


  34 in total

Review 1.  The ovarian androgen-producing cells: a 2001 perspective.

Authors:  Denis A Magoffin
Journal:  Rev Endocr Metab Disord       Date:  2002-01       Impact factor: 6.514

2.  Spironolactone in the treatment of polycystic ovary syndrome: effects on clinical features, insulin sensitivity and lipid profile.

Authors:  E Zulian; P Sartorato; S Benedini; G Baro; D Armanini; F Mantero; C Scaroni
Journal:  J Endocrinol Invest       Date:  2005-01       Impact factor: 4.256

3.  Imprinting of female offspring with testosterone results in insulin resistance and changes in body fat distribution at adult age in rats.

Authors:  C Nilsson; M Niklasson; E Eriksson; P Björntorp; A Holmäng
Journal:  J Clin Invest       Date:  1998-01-01       Impact factor: 14.808

Review 4.  Medical care from childhood to adulthood in type 1 and type 2 diabetes.

Authors:  G Costi; S Ten; N K Maclaren
Journal:  J Endocrinol Invest       Date:  2001-10       Impact factor: 4.256

5.  Targeted overexpression of luteinizing hormone in transgenic mice leads to infertility, polycystic ovaries, and ovarian tumors.

Authors:  K A Risma; C M Clay; T M Nett; T Wagner; J Yun; J H Nilson
Journal:  Proc Natl Acad Sci U S A       Date:  1995-02-28       Impact factor: 11.205

6.  Anti-androgen treatment increases circulating ghrelin levels in obese women with polycystic ovary syndrome.

Authors:  A Gambineri; U Pagotto; M Tschöp; V Vicennati; E Manicardi; A Carcello; M Cacciari; R De Iasio; R Pasquali
Journal:  J Endocrinol Invest       Date:  2003-07       Impact factor: 4.256

Review 7.  Nutrition, hormones, and breast cancer: is insulin the missing link?

Authors:  R Kaaks
Journal:  Cancer Causes Control       Date:  1996-11       Impact factor: 2.506

Review 8.  Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications.

Authors:  Evanthia Diamanti-Kandarakis; Andrea Dunaif
Journal:  Endocr Rev       Date:  2012-10-12       Impact factor: 19.871

9.  Racial differences in the association between sex hormone-binding globulin and adiposity in premenopausal women: the BioCycle study.

Authors:  Edwina H Yeung; Cuilin Zhang; Mary L Hediger; Jean Wactawski-Wende; Enrique F Schisterman
Journal:  Diabetes Care       Date:  2010-07-27       Impact factor: 19.112

10.  Hyperinsulinemia in polycystic ovary syndrome: relationship to clinical and hormonal factors.

Authors:  A Vidal-Puig; M Muñoz-Torres; E Jodar-Gimeno; C García-Calvente; P Lardelli; M E Ruiz-Requena; F Escobar-Jiménez
Journal:  Clin Investig       Date:  1994-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.